Skip to main content

Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.

Full Schedule

Full Schedule

  • Thursday, April 15, 2021
  • 9:00 AM – 9:55 AM
    Opening Session: Advances in Understanding of the Immunobiology of COVID-19 - Implications for Autoimmune and Autoinflammatory Diseases
  • 10:05 AM – 10:50 AM
    Pediatric Treatment Options for IMIDs
  • 11:00 AM – 12:00 PM
    Innovation Theater (non-accredited): Safety by the Numbers
  • 12:40 PM – 1:25 PM
    Update on CV risk in IMIDs
  • 1:35 PM – 2:35 PM
    Innovation Theater (non-accredited): OFEV® (nintedanib) capsules: A Treatment Journey
  • 3:15 PM – 4:00 PM
    New insights into the microbiome and IMIDs
  • 4:10 PM – 5:10 PM
    Innovation Theater (non-accredited)
  • 5:20 PM – 6:05 PM
    Improvements in Targeted Inflammatory Bowel Disease Management: Innovative Biologics and Small Molecules
  • 6:15 PM – 7:00 PM
    Pandemics – what the past tells us about our current and future of COVID19
  • Friday, April 16, 2021
  • 9:00 AM – 9:50 AM
    Co-Chair Cases: Collaborative Cases in IMID
  • 10:00 AM – 10:45 AM
    Healthcare Disparities in IMIDs
  • 10:55 AM – 11:55 AM
    Innovation Theater (non-accredited): COSENTYX® (secukinumab) for the axSpA Spectrum: 1 Biologic for non-radiographic axSpA (nr-axSpA) and ankylosing spondylitis (AS)
  • 12:35 PM – 1:20 PM
    Pregnancy and Autoimmune Disorders: Optimizing Outcomes for Mother and Baby
  • 1:30 PM – 2:30 PM
    Innovation Theater (non-accredited): What Sets Taltz Apart: An Overview of Long-Term Safety and Efficacy
  • 3:10 PM – 3:55 PM
    Advanced Management Practices in Atopic Dermatitis: Emerging Therapies for Moderate to Severe Disease
  • 4:05 PM – 4:50 PM
    Vaccines and IMIDs: Overcoming Obstacles
  • Saturday, April 17, 2021
  • 9:00 AM – 9:50 AM
    Understanding the Role of Sleep in IMIDs
  • 10:00 AM – 10:45 AM
    Management Strategies for Psoriatic Arthritis: Enhancing Recognition and Implementing Treat-to-Target Guidelines
  • 10:55 AM – 11:55 AM
    Innovation Theater (non-accredited): Early Recognition and Treatment of PsA
  • 12:35 PM – 1:20 PM
    Diet in the Management of Autoimmune Disease
  • 1:30 PM – 2:30 PM
    Innovation Theater (non-accredited): Elevating Treatment Goals: Exploring Multiple Domains to Lower Disease Activity in PsA
  • 3:10 PM – 3:55 PM
    Addressing Clinical Challenges in the Management of Systemic Lupus Erythematosus
  • 4:05 PM – 5:05 PM
    Innovation Theater (non-accredited): A Proven Oral Treatment for Psoriatic Arthritis and Psoriasis Patients
  • 5:15 PM – 6:00 PM
    COVID-19: IMID Updates
  • Sunday, April 18, 2021
  • 9:00 AM – 9:50 AM
    Co-Chair Cases: Collaborative Cases in IMID
  • 10:00 AM – 11:00 AM
    Innovation Theater (non-accredited): IL-23 and the AUTOIMMUNE AXIS
  • 11:10 AM – 11:55 AM
    Psoriasis Treatment Update: A Focus on Targeted Therapies
  • 12:05 PM – 12:50 PM
    Advancing Care of the Psoriatic Disease Patient: A Case-based Approach to Screening, Diagnosis and Management (non-accredited)
  • 1:30 PM – 2:15 PM
    Strategies for Improving IMID Outcomes: The Potential of JAK Inhibitors
  • 2:25 PM – 3:10 PM
    Biologic Therapies: Personalizing Care through Standardizing Care
  • 3:20 PM – 4:05 PM
    Closing Session: Managing Bone Health in the Setting of Chronic Inflammatory Diseases
  • Bonus Sessions
  • Advancing Multiple Sclerosis Treatment and Outcomes
  • Alopecia Areata and Its Treatment
  • Applying Guidelines in Clinical Practice: Highlights from the AAD-NPF Psoriasis Guidelines
  • Dermatology for the Rheumatologist
  • Dermatomyositis: Clinical Pearls and Pitfalls
  • Disorders of the Pouch
  • Hidradenitis: How to Measure it? How to Treat it?
  • Is Histology the Final Frontier for Endpoints in IBD?
  • Management of Common Autoimmune Blistering Diseases
  • Management of Inflammatory Eye Disease
  • Multidisciplinary Treatment of ANCA-Associated Vasculitis
  • New Insights in Eosinophilic Esophagitis Pathogenesis and Treatment 
  • Postoperative Crohn’s Disease
  • Precision Medicine in Sjögren’s Syndrome
  • Psoriatic Arthritis: Combining Clinics, Combining Efforts, Combining Therapies
  • Severe Ulcerative Colitis
  • Skin Considerations of Systemic Sclerosis
  • The Status of Targeted Therapies in the Management of irAEs
  • Understanding Behcet’s Disease